AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8124838 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive multifactor risk reduction
Number of subjects: 300
Study 8124838 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study 2666120 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinromide
Number of subjects: 0
Study 2666120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 171780 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole 800 mg t.d.s. for 5 days
Number of subjects: 10
Study 171780 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 10
Study 171780 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole
Number of subjects: 10
Study 31825067 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous energy restriction (CER) - 25% daily energy restriction
Number of subjects: 46
Study 31825067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent energy restriction (IER) - alternating ad libitum and 75% energy restriction days
Number of subjects: 46
Study 31825067 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (CER and IER)
Number of subjects: 46
Study 30830659 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1
Number of subjects: 724
Study 30830659 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 724
Study 27515097 — intervention group
Group type: EXPERIMENTAL
Intervention: LAS41008
Number of subjects: 671
Study 27515097 — intervention group
Group type: COMPARATOR
Intervention: Fumaderm®
Number of subjects: 671
Study 26384978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT) - Coping Cat
Number of subjects: 64
Study 26384978 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 64
Study 25308408 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40
Study 25308408 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 40
Study 22147286 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ibuprofen
Number of subjects: 80
Study 22147286 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ibuprofen
Number of subjects: 80
Study 19570752 — intervention group
Group type: EXPERIMENTAL
Intervention: auto-adjusting continuous positive airway pressure (auto-CPAP) with supplemental oxygen if required
Number of subjects: 24
Study 19570752 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study 17632222 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 112
Study 17632222 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 112
Study 17632222 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpiride
Number of subjects: 112
Study 17632222 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 112
Study 17632222 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine and Olanzapine
Number of subjects: 112
Study 17632222 — intervention group
Group type: COMPARATOR
Intervention: Risperidone and Sulpiride
Number of subjects: 112
Study 15103438 — intervention group
Group type: EXPERIMENTAL
Intervention: fosfluconazole (1000 mg bolus intravenous injection)
Number of subjects: 24
Study 15103438 — intervention group
Group type: COMPARATOR
Intervention: fluconazole (800 mg intravenous infusion)
Number of subjects: 24
Study 15103438 — intervention group
Group type: EXPERIMENTAL
Intervention: fosfluconazole
Number of subjects: 24
Study 15103438 — intervention group
Group type: COMPARATOR
Intervention: fluconazole
Number of subjects: 24
Study 15103438 — intervention group
Group type: EXPERIMENTAL
Intervention: fosfluconazole and fluconazole
Number of subjects: 24
Study 12234028 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg preoperatively for 10-14 days
Number of subjects: 30
Study 12234028 — intervention group
Group type: COMPARATOR
Intervention: Routine premedication
Number of subjects: 30
Study 9638548 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable dexamethasone sodium phosphate
Number of subjects: 42
Study 9638548 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal sterile saline)
Number of subjects: 42
Study 8088258 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (Neurontin) as add-on therapy at dosages of 600-2400 mg/day
Number of subjects: 240
Study 8088258 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (Neurontin) as add-on therapy
Number of subjects: 240
Study 2776093 — intervention group
Group type: EXPERIMENTAL
Intervention: oral solution
Number of subjects: 10
Study 2776093 — intervention group
Group type: EXPERIMENTAL
Intervention: film‐coated tablets
Number of subjects: 10
Study 2776093 — intervention group
Group type: EXPERIMENTAL
Intervention: enteric‐coated tablets
Number of subjects: 10
Study 1100188 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced Steristrip skin closures
Number of subjects: 512
Study 1100188 — intervention group
Group type: COMPARATOR
Intervention: Interrupted silk sutures
Number of subjects: 512
Study 30383097 — intervention group
Group type: EXPERIMENTAL
Intervention: Young fresh frozen plasma (yFFP) from male donors, 1 unit (approximately 250 mL) infused once weekly for 4 weeks
Number of subjects: 18
Study 30383097 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo), 250 mL infused once weekly for 4 weeks
Number of subjects: 18
Study 28294641 — intervention group
Group type: EXPERIMENTAL
Intervention: IDegLira
Number of subjects: 0
Study 28294641 — intervention group
Group type: COMPARATOR
Intervention: liraglutide added to basal insulin
Number of subjects: 0
Study 25841891 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular procaine benzylpenicillin and gentamicin once per day for 7 days (group A)
Number of subjects: 2490
Study 25841891 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular gentamicin once per day and oral amoxicillin twice per day for 7 days (group B)
Number of subjects: 2490
Study 25841891 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular procaine benzylpenicillin and gentamicin once per day for 2 days, then oral amoxicillin twice per day for 5 days (group C)
Number of subjects: 2490
Study 25841891 — intervention group
Group type: COMPARATOR
Intervention: Group A (standard treatment)
Number of subjects: 2490
Study 25841891 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (alternative regimen)
Number of subjects: 2490
Study 25841891 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (alternative regimen)
Number of subjects: 2490
Study 25841891 — intervention group
Group type: COMPARATOR
Intervention: Group A
Number of subjects: 2490
Study 25841891 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B
Number of subjects: 2490
Study 25841891 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C
Number of subjects: 2490
Study 24105909 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 393
Study 21671851 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-modifying drugs (DMDs) for RRMS
Number of subjects: 0
Study 21671851 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 19473411 — intervention group
Group type: EXPERIMENTAL
Intervention: BDDrFVIII
Number of subjects: 204
Study 17364435 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person ALSFRS-R interviews
Number of subjects: 68
Study 17364435 — intervention group
Group type: COMPARATOR
Intervention: Telephone administration of ALSFRS-R
Number of subjects: 68
Study 17364435 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary raters scoring
Number of subjects: 68
Study 17364435 — intervention group
Group type: COMPARATOR
Intervention: Back-up raters scoring
Number of subjects: 68
Study 15051844 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplements (MM), n = 142
Number of subjects: 453
Study 15051844 — intervention group
Group type: COMPARATOR
Intervention: Iron-only supplements (FE), n = 148
Number of subjects: 453
Study 11173790 — intervention group
Group type: EXPERIMENTAL
Intervention: GV 800 mg/400 mg
Number of subjects: 128
Study 11173790 — intervention group
Group type: EXPERIMENTAL
Intervention: GV 800 mg/200 mg
Number of subjects: 128
Study 11173790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 9060194 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.75 ml/kg)
Number of subjects: 60
Study 9060194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 9060194 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal and in vivo presentations of smoking and non-smoking stimuli
Number of subjects: 60
Study 2202619 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (4 x 1 tablet a day, 800 mg total daily dose)
Number of subjects: 36
Study 2202619 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (2 x 2 tablets a day, 800 mg total daily dose)
Number of subjects: 36
Study 2202619 — intervention group
Group type: COMPARATOR
Intervention: Group C (2 x 1 tablet a day, 400 mg total daily dose)
Number of subjects: 36
Study 7196807 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 30 mg/m2
Number of subjects: 28
Study 7196807 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 90 mg/m2
Number of subjects: 28
Study 7196807 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 30 mg/m2 and 90 mg/m2
Number of subjects: 28
Study 30716599 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated Y-BOCS
Number of subjects: 128
Study 30716599 — intervention group
Group type: COMPARATOR
Intervention: Clinician-rated Y-BOCS
Number of subjects: 128
Study 28910233 — intervention group
Group type: EXPERIMENTAL
Intervention: Beef protein (20 g mixed with plain water once a day)
Number of subjects: 24
Study 28910233 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (20 g mixed with plain water once a day)
Number of subjects: 24
Study 28910233 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (20 g mixed with plain water once a day)
Number of subjects: 24
Study 26727743 — intervention group
Group type: EXPERIMENTAL
Intervention: quinapril
Number of subjects: 95
Study 26727743 — intervention group
Group type: EXPERIMENTAL
Intervention: amlodipine
Number of subjects: 95
Study 26727743 — intervention group
Group type: EXPERIMENTAL
Intervention: hydrochlorothiazide
Number of subjects: 95
Study 26727743 — intervention group
Group type: EXPERIMENTAL
Intervention: losartan
Number of subjects: 95
Study 26727743 — intervention group
Group type: EXPERIMENTAL
Intervention: bisoprolol
Number of subjects: 95
Study 25305374 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised progressive resistance training (PRT) 2 days/week + unsupervised home-based exercise 5 days/week
Number of subjects: 73
Study 25305374 — intervention group
Group type: COMPARATOR
Intervention: Unsupervised home-based exercise 7 days/week
Number of subjects: 73
Study 22232507 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement (awareness plans)
Number of subjects: 117
Study 22232507 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (schedule setting, commitment)
Number of subjects: 117
Study 20190313 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal fixation
Number of subjects: 450
Study 20190313 — intervention group
Group type: COMPARATOR
Intervention: Replacement (total hip replacement or hemiarthroplasty)
Number of subjects: 450
Study 20190313 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Internal fixation and Replacement)
Number of subjects: 450
Study 20190313 — intervention group
Group type: EXPERIMENTAL
Intervention: Successfully healed fractures
Number of subjects: 450
Study 20190313 — intervention group
Group type: COMPARATOR
Intervention: Uncomplicated replacement
Number of subjects: 450
Study 20190313 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary replacement
Number of subjects: 450
Study 18575293 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-MCT/LCT plus 20 mg lidocaine
Number of subjects: 270
Study 18575293 — intervention group
Group type: COMPARATOR
Intervention: Propofol-MCT/LCT alone
Number of subjects: 270
Study 15814758 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck brace
Number of subjects: 100
Study 15814758 — intervention group
Group type: COMPARATOR
Intervention: Control group (no neck brace)
Number of subjects: 100
Study 11920317 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-valent pneumococcal conjugate vaccine
Number of subjects: 264
Study 11920317 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 264
Study 10715674 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine 45 mg (given on day 8)
Number of subjects: 90
Study 8610914 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg
Number of subjects: 173
Study 8610914 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 173
Study 8610914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 173
Study 1443840 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous cardiac pacing using low-impedance defibrillation-type polymer electrode pads
Number of subjects: 30
Study 1443840 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous cardiac pacing at 125% intensity for two minutes
Number of subjects: 30
Study 4052276 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous and oral propranolol (n = 44)
Number of subjects: 79
Study 4052276 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (n = 35)
Number of subjects: 79
Study 30552595 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology intervention (four weekly sessions, 30 min each)
Number of subjects: 256
Study 30552595 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology intervention
Number of subjects: 256
Study 30552595 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 256
Study 29695211 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplementation (ONS) plus Dietary Counselling (DC)
Number of subjects: 203
Study 29695211 — intervention group
Group type: COMPARATOR
Intervention: Dietary Counselling (DC) alone
Number of subjects: 203
Study 29695211 — intervention group
Group type: EXPERIMENTAL
Intervention: ONS consumption during follow-up
Number of subjects: 203
Study 27163534 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile flow (Group I, n=20)
Number of subjects: 40
Study 27163534 — intervention group
Group type: COMPARATOR
Intervention: Nonpulsatile flow (Group II, n=20)
Number of subjects: 40
Study 23686730 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam (0.5 mg/kg) plus oral ketamine (5 mg/kg)
Number of subjects: 60
Study 23686730 — intervention group
Group type: COMPARATOR
Intervention: Oral midazolam (0.5 mg/kg) plus oral placebo
Number of subjects: 60
Study 22343469 — intervention group
Group type: EXPERIMENTAL
Intervention: INVOS 5100C-PB
Number of subjects: 12
Study 22343469 — intervention group
Group type: EXPERIMENTAL
Intervention: FORE-SIGHT
Number of subjects: 12
Study 22343469 — intervention group
Group type: EXPERIMENTAL
Intervention: EQUANOX Classic 7600
Number of subjects: 12
Study 20827654 — intervention group
Group type: EXPERIMENTAL
Intervention: Pull up action during cycling
Number of subjects: 9
Study 17055081 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate control with pharmacological heart rate frequency optimization treatment combined with Holter monitoring
Number of subjects: 205
Study 17055081 — intervention group
Group type: COMPARATOR
Intervention: Rhythm control with sinus rhythm restoration and sequential antiarrhythmic drug treatment
Number of subjects: 205
Study 17055081 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate control
Number of subjects: 205
Study 17055081 — intervention group
Group type: COMPARATOR
Intervention: Rhythm control
Number of subjects: 205
Study 17055081 — intervention group
Group type: EXPERIMENTAL
Intervention: Both strategies
Number of subjects: 205
Study 15475602 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric contraction at 35 degrees (short length)
Number of subjects: 11
Study 15475602 — intervention group
Group type: COMPARATOR
Intervention: Isometric contraction at 75 degrees (long length)
Number of subjects: 11
Study 12173678 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored telephone counseling for mammography
Number of subjects: 1367
Study 12173678 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored mailed materials promoting mammography
Number of subjects: 1367
Study 12173678 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of tailored mail and telephone counseling
Number of subjects: 1367
Study 12173678 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no intervention)
Number of subjects: 1367
Study 9872350 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-dependent subjects
Number of subjects: 12
Study 9872350 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 12
Study 7789590 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg vaginal PGE2 gel
Number of subjects: 68
Study 7789590 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mg intracervical PGE2
Number of subjects: 68
Study 2261388 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole abdominal radiotherapy (n = 56)
Number of subjects: 109
Study 2261388 — intervention group
Group type: COMPARATOR
Intervention: Chlorambucil (n = 53)
Number of subjects: 109
Study 7430701 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunscreens with different sun protection factors
Number of subjects: 0
Study 31530607 — intervention group
Group type: EXPERIMENTAL
Intervention: Central line removal at 100 mL/kg/day of enteral intake
Number of subjects: 0
Study 31530607 — intervention group
Group type: COMPARATOR
Intervention: Control group: Central line removal at 140 mL/kg/day of enteral intake
Number of subjects: 0
Study 27875389 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 58
Study 27875389 — intervention group
Group type: COMPARATOR
Intervention: Gabapentin (GP)
Number of subjects: 58
Study 25660340 — intervention group
Group type: COMPARATOR
Intervention: Educational group (E)
Number of subjects: 44
Study 25660340 — intervention group
Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation therapy (PMR)
Number of subjects: 44
Study 25660340 — intervention group
Group type: COMPARATOR
Intervention: PMR plus exercise (PMR Plus)
Number of subjects: 44
Study 23610236 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbolic play then joint attention intervention
Number of subjects: 33
Study 23610236 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint attention then symbolic play intervention
Number of subjects: 33
Study 23610236 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control period
Number of subjects: 33
Study 21334013 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass
Number of subjects: 200
Study 21334013 — intervention group
Group type: COMPARATOR
Intervention: On-pump coronary artery bypass
Number of subjects: 200
Study 21334013 — intervention group
Group type: EXPERIMENTAL
Intervention: Early brain magnetic resonance imaging
Number of subjects: 200
Study 21334013 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up imaging
Number of subjects: 200
Study 21334013 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 200
Study 19253084 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% one‐repetition maximum (1‐RM)
Number of subjects: 35
Study 19253084 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% one‐repetition maximum (1‐RM)
Number of subjects: 35
Study 19253084 — intervention group
Group type: EXPERIMENTAL
Intervention: 90% one‐repetition maximum (1‐RM)
Number of subjects: 35
Study 19253084 — intervention group
Group type: EXPERIMENTAL
Intervention: 110% one‐repetition maximum (1‐RM)
Number of subjects: 35
Study 19253084 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 35
Study 17091205 — intervention group
Group type: EXPERIMENTAL
Intervention: Dust spiked with glucan
Number of subjects: 36
Study 17091205 — intervention group
Group type: EXPERIMENTAL
Intervention: Dust spiked with aldehydes
Number of subjects: 36
Study 17091205 — intervention group
Group type: COMPARATOR
Intervention: Clean air or office dust
Number of subjects: 36
Study 17091205 — intervention group
Group type: COMPARATOR
Intervention: Office dust or clean air
Number of subjects: 36
Study 14764189 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (twice a week for 8 weeks, total of 16 sessions)
Number of subjects: 10
Study 14764189 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 10
Study 11318841 — intervention group
Group type: EXPERIMENTAL
Intervention: Kir6.2 E23K variant
Number of subjects: 692
Study 11318841 — intervention group
Group type: COMPARATOR
Intervention: SUR1 promoter variants
Number of subjects: 692
Study 9597863 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (CEZ) administered on the day of operation
Number of subjects: 255
Study 9597863 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (CEZ) administered for 3 days
Number of subjects: 255
Study 9597863 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (CEZ) or cefotiam (CTM) administered for 2 days
Number of subjects: 255
Study 9597863 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (CEZ) or cefotiam (CTM) administered for 4 days
Number of subjects: 255
Study 9597863 — intervention group
Group type: COMPARATOR
Intervention: Shorter antimicrobial administration periods
Number of subjects: 255
Study 7940731 — intervention group
Group type: EXPERIMENTAL
Intervention: T cell depletion using anti-CD8 and anti-CD6 antibodies plus complement (n = 28)
Number of subjects: 48
Study 7940731 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) and cyclosporine (CsA) (n = 25)
Number of subjects: 48
Study 3024542 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin
Number of subjects: 100
Study 29409737 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing desk intervention (16 weeks duration)
Number of subjects: 49
Study 29409737 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional seated desks)
Number of subjects: 49
Study 27793147 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined microsavings and HIV/STI risk reduction intervention (treatment condition)
Number of subjects: 107